Adiponectin and protection against type 2 diabetes mellitus

Lancet

Volumn 361, Issue 9353, 2003, Pages 226-228

  Spranger, Joachim ^a   Kroke, Anja ^b   Möhlig, Matthias ^b   Bergmann, Manuela M ^b   Ristow, Michael ^b   Boeing, Heiner ^b   Pfeiffer, Andreas F H ^b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALCOHOL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EXERCISE; FEMALE; GENDER; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTECTION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; SMOKING;

EID: 0037452139     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12255-6     Document Type: Article

References (5)

1. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 270:1995;26746-26749.
2. Berg A.H., Combs T.P., Du X., Brownlee M., Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 7:2001;947-953.
3. Ouchi N., Kihara S., Arita Y., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 102:2000;1296-1301.
4. Kubota N., Terauchi Y., Yamauchi T., et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 24:2002;24.
5. Lindsay R.S., Funahashi T., Hanson R.L., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 360:2002;57-58.